Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Steady-state Pharmacokinetics of Atazanavir/Cobicistat and Darunavir/Cobicistat in Healthy Volunteers
NCT02589158Phase 1Completed
- Sponsor
- St Stephen's AIDS Trust
- Start
- Nov 2015
- Primary completion
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of atazanavir, darunavir and cobicistat in human immunodeficiency virus infection (HIV), sponsored by St Stephen's AIDS Trust. Primary endpoints: Trough Plasma Concentration at Day 30, Maximum Plasma Concentration at Day 30 and 3 more. Started Nov 2015; status: completed.
02
Drugs
atazanavirdarunavircobicistat
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT02589158.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02589158.